1.Yi Z, Wu Z. Control of Aids Epidemic in China. Bulletin of the Chinese Academy of Sciences. 2000(2):106-111.
2. Zunyou W. Evolution of China's response to HIV/AIDS. Lancet (London, England). 2007;9562(369).
3.Yan Y, Wu S, Chen L, et al. Shift in HIV/AIDS Epidemic in Southeastern China: A Longitudinal
Study from 1987 to 2015. International Journal of Environmental Research and Public Health. 2016;13(8):794.
4 .Sun W, Wu M, Qu P, Lu C, Wang L. Quality of Life of People Living with HIV/AIDS under
the New Epidemic Characteristics in China and the Associated Factors. PLOS ONE. 2013;8(5).
Huang MB, Ye L, Liang BY, et al. Characterizing the HIV/AIDS Epidemic in the United
States and China. International Journal of Environmental Research & Public Health. 2015;13(1):ijerph13010030.
6.Tang Q, Lu H. HIV/AIDS responses in China should focus on the impact of global integration.
BioScience Trends. 2018;12(5):507-509.
7.Zhongwei J, Yuhua R, Zuhong L. HIV incidence and mortality in China. Lancet. 2015;385(9977):1510-1510.
8.Yang S, Wu J, Ding C, et al. Epidemiological features of and changes in incidence
of infectious diseases in China in the first decade after the SARS outbreak: an observational
trend study. Lancet Infectious Diseases. 2017;17(7):716-725.
9.National Center for AIDS/STD Control and Prevention. National AIDS and STD epidemic
in the third quarter of 2018. Chinese Journal of AIDS & STD. 2018;24(11):1075. (In Chinese)
10.Wang L, Xiao Y, Tian X, Ruan J, Chen W, Yu Y. HIV infection in Xi’an, China: epidemic
characterization, risk factors to false positives and potential utility of the sample-to-cutoff
index to identify true positives using Architect HIV Ag/Ab combo. Antimicrobial Resistance and Infection Control. 2019;8(1):9.
11.Yu ES, Xie Q, ., Zhang K, ., Lu P, ., Chan LL. HIV infection and AIDS in China, 1985
through 1994. American Journal of Public Health. 1996;86(8):1116-1122.
12. Liu Z, Shi O, Yan Q, et al. Changing epidemiological patterns of HIV and AIDS in China
in the post-SARS era identified by the nationwide surveillance system. BMC Infectious Diseases. 2018;18(1):700.
13.National Center for AIDS/STD Control and Prevention. Update on the AIDS/STD epidemic
in China and main response in control and prevention in December 2015. Chinese Journal of AIDS & STD. 2016;22(2):69.(In Chinese)
14. Li W, Jiang J, Su J, et al. Commercial Sexual Behaviors Among Male Rural-to-Urban
Migrants in Western China: Implications for HIV Prevention. Asia Pacific Journal of Public Health. 2017;29(5):101053951770902.
15. Ministry of Health of China. Protocol for prevention of mother-to-child transmission of HIV, syphilis and Hepatitis
B. Beijing: Ministry of Health, 2011.
16.Sun XH, Fan L, Wu ZY, et al. Evolution of information-driven HIV/AIDS policies in
China. International Journal of Epidemiology. 2010;39 Suppl 2(Suppl 2):ii4.
17.Wu Z, Wang Y, Detels R, Rotheramborus MJ. China AIDS policy implementation: reversing
the HIV/AIDS epidemic by 2015. International Journal of Epidemiology. 2010;39.
18.Wang A, Qiao Y, Wang L, et al. Integrated prevention of mother-to-child transmission
for human immunodeficiency virus, syphilis and hepatitis B virus in China. Bulletin of The World Health Organization. 2015;93(1):52-56.
19.Zeng H, Chow EPF, Zhao Y, et al. Prevention of mother-to-child HIV transmission cascade
in China: a systematic review and meta-analysis. Sexually Transmitted Infections. 2016;92(2):116-123.
20. Kaufman J, Jing J. China and AIDS--The Time to Act Is Now. Science. 2002;296(5577):2339-2340.
21.Standing Committee of the National People’s Congress. Decision on the prohibition of narcotic drugs. Beijing: Standing Committee of the National People’s Congress. 1990.
22.Ministry of Public Security. Administration of compulsory detoxification at rehabilitation centres. Beijing: Ministry of Public Security Document number 49. 2000.
23.Lin C, Wu Z, Detels R. Family support, quality of life and concurrent substance use
among methadone maintenance therapy clients in China. Public Health. 2011;125(5):269-274.
24.State Council of People’s Republic of China. Regulations for the management of blood
products. Beijing: State Council Document number 208. 1996.
25.Lei Z, Chow EPF, Jun J, et al. HIV prevalence in China: integration of surveillance
data and a systematic review. Lancet Infectious Diseases. 2013;13(11):955-963
26.Dou Z, Chen RY, Xu J, et al. Changing baseline characteristics among patients in the
China National Free Antiretroviral Treatment Program, 2002-09. International Journal of Epidemiology. 2010;39 Suppl 2(suppl 2):ii56.
27.Xing J, Li Y, Tang W, et al. HIV/AIDS Epidemic Among Older Adults in China During
2005-2012: Results From Trend and Spatial Analysis. Clinical Infectious Diseases. 2014;59(2).
28.Huang ZJ, He N, Nehl EJ, et al. Social Network and Other Correlates of HIV Testing:
Findings from Male Sex Workers and Other MSM in Shanghai, China. Aids and Behavior. 2012;16(4):858-871.
29. Li R, Pan X, Ma Q, et al. Prevalence of prior HIV testing and associated factors among
MSM in Zhejiang Province, China: a cross-sectional study. Bmc Public Health. 2016;16(1):1152.